In-Depth Examination Of 6 Analyst Recommendations For Evolent Health
In-Depth Examination Of 6 Analyst Recommendations For Evolent Health
深入研究分析师对Evolent Health的6条建议
Evolent Health (NYSE:EVH) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在过去的三个月中，有6位分析师对Evolent Health（纽约证券交易所代码：EVH）进行了分析，揭示了从看涨到看跌的不同观点。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的评级，展示了过去30天情绪的演变，并将其与前几个月进行了比较。
Analysts have set 12-month price targets for Evolent Health, revealing an average target of $44.0, a high estimate of $52.00, and a low estimate of $38.00. A 3.3% drop is evident in the current average compared to the previous average price target of $45.50.
分析师已经为Evolent Health设定了12个月的目标股价，显示平均目标股价为44.0美元，最高估计为52.00美元，低估值为38.00美元。与之前的平均目标价45.50美元相比，当前的平均价格下降了3.3％。
Investigating Analyst Ratings: An Elaborate Study
调查分析师评级：一项详尽的研究
The perception of Evolent Health...
通过分析师...
登录免费看全文
登录/注册